Trials / Unknown
UnknownNCT05757804
Study of 18F-0502B PET Imaging Targeting α-synuclein in the Diagnosis of α-synuclein-related Diseases
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- Huashan Hospital · Academic / Other
- Sex
- All
- Age
- 60 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
To explore the diagnostic value of 18F-0502B brain imaging for α-Syn protein-related diseases in patients with PD. To evaluate the imaging range of α-Syn protein density in patients with α-Syn protein-related diseases and to assess the level of abnormal α-Syn protein deposition by PET imaging with this PET tracer, and its safety in human studies.
Conditions
Timeline
- Start date
- 2023-03-17
- Primary completion
- 2023-07-15
- Completion
- 2024-01-14
- First posted
- 2023-03-07
- Last updated
- 2023-03-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05757804. Inclusion in this directory is not an endorsement.